Associated Papers
Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum.
Li S et al.
Nature Communications, 2025
41261115 (PubMed )
Supplement: 41467_2025_65164_MOESM6_ESM.xlsx › Figure_3C
Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers.
Lin I et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
38370823 (PubMed )
Supplement: media-1.xlsx › Table_S5_CHIPVAFlt03
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia.
Docking TR et al.
Nature Communications, 2021
33931648 (PubMed )
Supplement: 41467_2021_22625_MOESM4_ESM.xlsx › Supplementary_Data_17
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
Shankar GM et al.
Acta Neuropathologica Communications, 2014
25589003 (PubMed )
Supplement: 40478_2014_167_MOESM1_ESM.xlsx › Supplementary_Table_6
Genetic variants and normal tissue toxicity after radiotherapy: a systematic review.
Andreassen CN et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 2009
Genetic markers for prediction of normal tissue toxicity after radiotherapy.
Alsner J et al.
Seminars in Radiation Oncology, 2008
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
Andreassen CN
Acta Oncologica (stockholm, Sweden), 2005
Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.
Severin DM et al.
International Journal of Radiation Oncology, Biology, Physics, 2001
Select a paper to view details